| Literature DB >> 23710163 |
Hengbo Shi1, Jun Luo, Jiangjiang Zhu, Jun Li, Yuting Sun, Xianzi Lin, Liping Zhang, Dawei Yao, Huaiping Shi.
Abstract
To explore the function of PPAR γ in the goat mammary gland, we cloned the whole cDNA of the PPAR γ gene. Homology alignments revealed that the goat PPAR γ gene is conserved among goat, bovine, mouse, and human. Luciferase assays revealed that rosiglitazone enhanced the activity of the PPAR γ response element (PPRE) in goat mammary epithelial cells (GMECs). After rosiglitazone (ROSI) treatment of GMECs, there was a significant (P < 0.05) increase in the expression of genes related to triacylglycerol synthesis and secretion: LPL, FASN, ACACA, PLIN3, FABP3, PLIN2, PNPLA2, NR1H3, SREBF1, and SCD. The decreases in expression observed after knockdown of PPAR γ relative to the control group (Ad-NC) averaged 65%, 52%, 67%, 55%, 65%, 58%, 85%, 43%, 50%, and 24% for SCD, DGAT1, AGPAT6, SREBF1, ACACA, FASN, FABP3, SCAP, ATGL, and PLIN3, respectively. These results provide direct evidence that PPAR γ plays a crucial role in regulating the triacylglycerol synthesis and secretion in goat mammary cells and underscore the functional importance of PPAR γ in mammary gland tissue during lactation.Entities:
Year: 2013 PMID: 23710163 PMCID: PMC3654327 DOI: 10.1155/2013/310948
Source DB: PubMed Journal: PPAR Res Impact factor: 4.964
Primer pairs used in PCR for amplification of goat PPARG from mammary cDNA.
| Name of fragment | Sequence | Product length |
|---|---|---|
| PPAR | Forward: 5′-ATGGTTGACACAGAGATGCCG-3′ | 1413 bp |
| Reversal: 5′-GTAGATTTCCTGTAGAAGTGGGTGG-3′ | ||
| PPAR | Outer: 5′-AAGTAACTCTCCTAAAATACGGCG-3′ | 516 bp |
| Inner: 5′-CCAGAAAATGACGGACCTCAGGCAGA-3′ | 160 bp | |
| PPAR | GSP1: 5′-CGGTGATTTGTCTGTCGTCTTTC-3′ | 750 bp |
| GSP2: 5′-GATACAGGCTCCACTTTGATTGC-3′ | 260 bp |
Characteristics of shRNA used in the experiment.
|
|
Three shRNAs (numbers stand for their position in cDNA) were designed, and each shRNA was added with restriction sites BamH I and Xho I. The loop domain (lower-case nucleotides) contained a Scal I site.
Characteristics of primer pairs used, amplicon length, and efficiency of reaction in the RT-qPCR.
| Accession# | Gene | Primer sequence (5′ to 3′) | Product length (bp) | Efficiency |
|---|---|---|---|---|
| JN236219.1 |
| Forward: CTCCAACCTCAACCACTACGG | 171 | 2.09 |
| JI861797.1 |
| Forward: AAGCAAGTTGCCCATCCTCA | 101 | 2.17 |
| X91503# |
| Forward: GTACAGATGCAGCCTCATTTCC | 81 | 2.18 |
| DQ380249.1 |
| Forward: CCACTGGGACCTGAGGTGTC | 101 | 2.11 |
| NM_001009350 |
| Forward: GATGAGACCACGGCAGATG | 120 | 2.14 |
| DQ915966.3 |
| Forward: GGGCTCCACCACCGTGTTCCA | 226 | 2.13 |
| AJ431207 |
| Forward: GCAAGTTCCACGGCACAG | 249 | 2.16 |
| DQ997818 |
| Forward: AGGACACTTGCCACCTCATTC | 169 | 2.18 |
| GU332719 |
| Forward: CATCAACCCCATCTTCGAGTT | 163 | 2.13 |
| HQ846826 |
| Forward: TACGATGATACAGATGAATCCCAC | 203 | 2.16 |
| HQ846827 |
| Forward: GGTGGAGGGTCAGGAGAAA | 170 | 1.13 |
| GQ918145 |
| Forward: GGAGCTTATCCAGGCCAATG | 226 | 2.24 |
| HQ589347.1 |
| Forward: CCTTCACCACCGTTGACTTCT | 145 | 2.21 |
| DV935188# |
| Forward: CCATGTGCACTTCAAGGAGGA | 108 | 2.10 |
| GU947654 |
| Forward: CCATCGCCTGTGGAGTCAC | 257 | 2.10 |
| HM443643.1 |
| Forward: CTGCTGACCGACATAGAAGACAT | 81 | 2.20 |
Annealing temperature for all primers in this table is 60°C.
ACACA, acetyl-coenzyme A carboxylase alpha; AGPAT6, 1-acylglycerol-3-phosphate O-acyltransferase 6; CD36, thrombospondin receptor; DGAT1, diacylglycerol acyl transferase 1; FABP3, fatty acid binding protein 3; FASN, fatty acid synthase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; LPL, Lipoprotein lipase; NR1H3, liver X receptor α; PLIN2, perilipin2; PLIN3, perilipin3; PNPLA2, patatin-like phospholipase domain containing 2; PPARG, peroxisome proliferator-activated receptor γ; SCAP, cleavage activating protein; SCD, stearoyl-CoA desaturase; SREBF1, Sterol regulatory element-binding transcription factor 1.
#The primer sequences are from bovine.
Figure 1Structure prediction and phylogenetic alignment analysis of the dairy goat PPARγ gene. (a) Phylogenetic tree showing the relatedness of PPARγ CDS sequences of mouse (Mus), human (Homo), bovine (Bos), sheep (Ovis), and goat (Capra). The alignment was performed with ClustalW. The digital “0.005” is the genetic ruler. (b) The tertiary structure prediction of goat PPARγ. Alpha helices are colored in crimson, beta sheets in yellow, turnings in blue, and irregular curl in white. (c) The ligand binding domain prediction of goat PPARγ. The amino acids involved in the binding sites are colored in blue. The ligands colored in laurel green. In grey is the predicted tertiary structure of the goat PPARγ protein.
Figure 2ROSI activated the PPARγ response element (PPRE) effectively in GMECs. DMECs were transfected with pGL3-basic-PPRE×3 and pRL-TK vectors. After transfection, cells were treated with different concentration of ROSI. Luciferase and Renilla luciferase assays were performed in triplicate, and the results were expressed relative to the control (0 μmol/L). Luciferase activity data were normalized with Renilla luciferase activity. The data represent mean ± SD of three independent experiments. b P < 0.05 versus the control group.
Figure 3ROSI affects the expression of genes coding for proteins involved in lipid synthesis in GMECs through PPARγ signaling. Dairy goat mammary epithelial cells were treated with ROSI and harvested at 0, 12, and 24 h. (a) Genes related to lipid droplet formation (PLIN2 and PLIN3) and hydrolysis of triacylglycerols (PNPLA2). (b) Genes related to fatty acid synthesis (FASN and ACACA) and desaturation (SCD). (c) Genes related to cellular fatty acid uptake (FABP3, LPL). (d) Genes related to regulation of transcription (SREBF1 and NR1H3). The data are mean ± SD of three independent experiments. b P < 0.05 versus the control group (0 h). c P < 0.01 versus the control group (0 h).
Figure 4Efficacy screening of the three designed shRNA via images analysis. pDsRed1-C1-PPAR vector was transfected as a control ((a1), (b1), and (c1)). The three tested shRNA (sh500, sh614, and sh1006) as pENTR/CMV-GFP/U6-shRNA construct were cotransfected with pDsRed1-C1-PPARvector. The transduction efficiency was estimated by the level of green fluorescent protein (GFP) expression ((a3), (b3) and (c3)). Shown are representative images of the PPARγ expression (in red) after a 48 h cotransfection. (a1), (b1), and (c1) show high transfection and expression of PPARγ construct vector. (a2), (b2), and (c2) show reduction of PPARγ expression after addition of shRNA construct, while (a3), (b3), and (c3) show efficacy of shRNA transfection as shown by the green color (i.e., GFP). Images were obtained by a fluorescence microscope (Leica, DMI4000B, Germany) at 100x magnification. The images clearly show that the sh1006 had the highest effect on PPARγ vector expression (c2).
Figure 5Efficacy screening of the two designed shRNA via RT-qPCR and western blot. The efficiency of Ad-sh614 and Ad-sh1006 (transduced with two adenoviruses at 200 multiplicity of infection for 48 h) in decreasing PPARG expression in dairy goat mammary epithelia cells was assessed by RT-qPCR (a) and western blot (b). The data revealed that Ad-sh1006 had the highest knockdown of PPARγ transcript and protein; thus, it was used in the subsequent experiments.
Figure 6Effect of PPARγ knockdown on genes coding for proteins involved in milk fat synthesis in GMECs. The expression of genes related to fatty acid synthesis (a), cellular fatty acid uptake (b), triacylglycerol synthesis (c), lipid droplet formation and triacylglycerol hydrolysis (d), and transcriptional regulation (e) was assessed in goat epithelial cells (GMECs) after transduction with Ad-sh1006 at 200 MOI for 48 h. The data represent the mean ± SD of cells transfected with control (Ad-NC) or Ad-sh1006 vector in triplicate per experiment. b P < 0.05 versus the control group.